Syndax Pharmaceuticals
SNDX
SNDX
189 hedge funds and large institutions have $2.15B invested in Syndax Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 177 → 189 (+12)
6% more call options, than puts
Call options by funds: $8.74M | Put options by funds: $8.25M
6.01% less ownership
Funds ownership: 112.28% → 106.26% (-6%)
Holders
189
Holding in Top 10
10
Calls
$8.74M
Puts
$8.25M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$16.9M | |
| 3 | +$16M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.1M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$12.8M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$36M | |
| 3 | -$25.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.3M |
| 5 |
Millennium Management
New York
|
-$6.21M |